This observational study, called CHOICES, is looking at how the way medical information is shared affects treatment decisions for people with advanced cancer. Researchers want to understand how different details, like risks, benefits, time commitment, and costs, influence your preference for palliative systemic therapy (treatment to relieve symptoms and improve quality of life). You could join if you are 18 or older, have advanced solid tumor or aggressive lymphoma, have been seen at MD Anderson Cancer Center Thoracic and Lymphoma Oncology Clinics for a follow-up, and have had at least two lines of palliative systemic cancer therapies. The study will measure overall survival (how long people live) over about one year. This study is not testing a new drug, but rather how information is presented.

Study design

This is an observational study with 400 participants. It uses a randomized case vignette design, meaning you'll respond to hypothetical scenarios rather than your own health situation.

What's involved

You will complete about 16 questionnaires with questions about your quality of life, anxiety, health, and case scenarios.

Compensation

Not stated in the trial record.

Follow-up

Overall survival will be measured through study completion, which is an average of 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.